Reference
Sirotova Z, et al. Treatment duration of upfront abiraterone acetate (AA) for metastatic castration resistant prostate cancer (MCRPC) patients. Tumori 105 (Suppl.): 128-129 abstr. E22, No. 6, 2019. Available from: URL: http://doi.org/10.1177/0300891619872589 [abstract]
Rights and permissions
About this article
Cite this article
Abiraterone-acetate. Reactions Weekly 1835, 10 (2020). https://doi.org/10.1007/s40278-020-87454-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-87454-0